RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Charles T. Spencer to CD4-Positive T-Lymphocytes

Back to Details
This is a "connection" page, showing publications Charles T. Spencer has written about CD4-Positive T-Lymphocytes.
Charles T. Spencer
Connection Strength
0.073
CD4-Positive T-Lymphocytes
  1. Sefat KMSR, Kumar M, Kehl S, Kulkarni R, Leekha A, Paniagua MM, Ackart DF, Jones N, Spencer C, Podell BK, Ouellet H, Varadarajan N. An intranasal nanoparticle vaccine elicits protective immunity against Mycobacterium tuberculosis. Vaccine. 2024 09 17; 42(22):125909.
    View in: PubMed
    Score: 0.047
  2. Abate G, Spencer CT, Hamzabegovic F, Blazevic A, Xia M, Hoft DF. Mycobacterium-Specific ?9d2 T Cells Mediate Both Pathogen-Inhibitory and CD40 Ligand-Dependent Antigen Presentation Effects Important for Tuberculosis Immunity. Infect Immun. 2016 02; 84(2):580-9.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support